Lazard Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-449
| Closed | -$67K | – | 2652 |
|
|
2022
Q3 | $67K | Sell |
449
-794
| -64% | -$118K | ﹤0.01% | 1667 |
|
|
2022
Q2 | $181K | Buy |
1,243
+368
| +42% | +$53.6K | ﹤0.01% | 1310 |
|
|
2022
Q1 | $103K | Sell |
875
-4
| -0.5% | -$471 | ﹤0.01% | 1388 |
|
|
2021
Q4 | $121K | Sell |
879
-8,117
| -90% | -$1.12M | ﹤0.01% | 1389 |
|
|
2021
Q3 | $1.25M | Buy |
8,996
+8,114
| +920% | +$1.13M | ﹤0.01% | 1012 |
|
|
2021
Q2 | $85K | Buy |
882
+776
| +732% | +$74.8K | ﹤0.01% | 1399 |
|
|
2021
Q1 | $7K | Sell |
106
-514
| -83% | -$33.9K | ﹤0.01% | 1781 |
|
|
2020
Q4 | $53K | Buy |
+620
| New | +$53K | ﹤0.01% | 1372 |
|